GH Research PLC (GHRS)
Nasdaq: GHRS · Pharmaceutical Preparations · Dublin 2, IE · filing with the SEC since 2021
Who runs GH Research PLC
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Valcheva Velichka
Chief Executive Officer. First filing Apr 2026, latest Apr 2, 2026, 0 filings in all.
Officers reporting now
4
of 8 people with a filing in the last fifteen months
Directors reporting now
4
8 people on the record since 2026
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Valcheva Velichka | Chief Executive Officer | Apr 2026 | Apr 2, 2026 | none |
| Cameron Aaron Luke | Chief Operating Officer | Apr 2026 | Apr 2, 2026 | none |
| Halle Magnus Clemensen | Managing Director, Ireland | Apr 2026 | Apr 2, 2026 | none |
| Ryan Julie | VP, Finance | Apr 2026 | Apr 2, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Schonharting Florian | director | Apr 2026 | Sep 9, 2026 | none |
| Forer Michael | director | Apr 2026 | Aug 13, 2026 | none |
| Hanley Dermot John | director | Apr 2026 | Aug 13, 2026 | none |
| Moore Duncan | director | Apr 2026 | Aug 13, 2026 | none |
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.